Eder H G, Leber K A, Eustacchio S, Pendl G
Department of Neurosurgery, Karl-Franzens University, Auenbruggerplatz 29, 8036 Graz, Austria.
Childs Nerv Syst. 2001 May;17(6):341-6; discussion 347. doi: 10.1007/s003810000435.
Despite advances in microneurosurgery, the surgical management of deep-seated lesions is still associated with a high risk. Gamma knife radiosurgery (GKRS), however, has improved the outcome of cerebral tumors and arteriovenous malformations (AVMs) in delicate areas.
Between March 1992 and June 1998, 50 children (age 1-16 years) with intracranial lesions were treated with GKRS. There were 12 low-grade gliomas, 12 high-grade gliomas, 7 craniopharyngiomas, 3 hamartomas, 2 meningiomas of the skull base, 2 vestibular schwannomas, 1 pituitary adenoma, 1 choroid plexus papilloma, and 10 AVMs. The mean size of the pathologies was 4.6 cm3 (range: 0.21-25.5 cm3). A mean marginal dose of 16 Gy (8-25 Gy) was applied to a mean isodose surface of 50% (35-90%). Clinical and neuroradiological follow-up were analyzed for outcome. Follow-up periods of 45 of these patients ranged from 8 to 79 months (mean 36 months); 5 patients were lost to follow-up. Neoplasms decreased in size in 15 cases (41%), remained unchanged in 13 patients (35%), and increased in 9 cases (24%). AVMs obliterated in 3 children (38%) within 24 months. Neurological follow-up demonstrated improved clinical status in 7 patients (15.5%), stable neurological status in 31 cases (69%) and clinical deterioration in 7 patients (15.5%). The treatment was well tolerated and no complications occurred.
GKRS represents a safe and effective treatment option for benign neoplasms or AVMs in pediatric patients and may extend survival times of children with malignant lesions.
尽管显微神经外科手术取得了进展,但深部病变的手术治疗仍具有较高风险。然而,伽玛刀放射外科手术(GKRS)改善了精细区域脑肿瘤和动静脉畸形(AVM)的治疗效果。
1992年3月至1998年6月,50例年龄在1至16岁的颅内病变患儿接受了GKRS治疗。其中包括12例低级别胶质瘤、12例高级别胶质瘤、7例颅咽管瘤、3例错构瘤、2例颅底脑膜瘤、2例前庭神经鞘瘤、1例垂体腺瘤、1例脉络丛乳头状瘤和10例AVM。病变的平均大小为4.6立方厘米(范围:0.21至25.5立方厘米)。平均边缘剂量为16 Gy(8至25 Gy),平均等剂量面为50%(35%至90%)。对临床和神经放射学随访结果进行分析。其中45例患者的随访期为8至79个月(平均36个月);5例患者失访。15例(41%)肿瘤体积缩小,13例(35%)保持不变,9例(24%)增大。3例(38%)儿童的AVM在24个月内闭塞。神经学随访显示,7例(15.5%)患者临床状态改善,31例(69%)患者神经状态稳定,7例(15.5%)患者临床恶化。该治疗耐受性良好,未发生并发症。
GKRS是小儿患者良性肿瘤或AVM的一种安全有效的治疗选择,可能延长恶性病变患儿的生存期。